Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on February 13, 2018. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The document primarily acts as a cover for a press release dated February 13, 2018, included as Exhibit 99.1.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing text does not provide a clear value for any financial metric.
Material Changes
The filing text does not disclose material changes versus prior comparable periods. The document serves only to reference an external press release without summarizing its content.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumably contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Key Facts for Investor Verification
- Verify the content of the press release dated February 13, 2018, referenced as Exhibit 99.1, as the filing itself contains no operational or financial details.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Executive Officer, André Choulika, signed the report on behalf of the registrant.